Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06885268 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Noradrenaline Versus Standard Blood Pressure Management for Perioperative Hypotension in Non-cardiac Surgery

Study acronym: HYP-NOR
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Start date: Jun 25, 2025 to Jun 24, 2025
    • Eligibility criteria expanded, about 23 words
    • Secondary endpoints: details revised at 4 of 11 entries
  2. Minor Study title shortened, about 6 wordsv5
  3. Notable Start date: Mar 29, 2025 to Jun 25, 2025
    • Secondary endpoints: 12 to 11
    • Study description expanded, about 16 words
    • Site details revised at 1 of 5 sites
    v4
  4. Minor Site details revised at 3 of 5 sitesv3
  5. Notable Trial status: Not Yet Recruiting to Recruiting
    • Site details revised at 5 of 5 sites
    v2
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The effect of noradrenaline infusion versus standard blood pressure management on perioperative HYPotension in NOn-caRdiac surgery. The study aims to determine whether perioperative noradrenaline infusion is superior to standard blood pressure management for the occurrence of perioperative hypotension.
Trial Details
NCT Number NCT06885268
Lead Sponsor Jagiellonian University
Collaborators: Medical Research Agency, Poland
Conditions
(from sponsor)
Blood Pressure Management, Intraoperative Hypotension, Non-cardiac Surgery
Related terms Hypotension
Enrollment 750 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov